Briggs Morrison, a veteran of in-person and now virtual US Food and Drug Administration advisory committee meetings, believes an in-person event may be better when a product’s approval is on the agenda.
Morrison is CEO of Syndax Pharmaceuticals, Inc., a clinical-stage company focused on cancer therapies, and was among the first...